Global Marijuana Market Could Reach $18.6 Billion by 2027: UN Report

Dec.12.2022
Global Marijuana Market Could Reach $18.6 Billion by 2027: UN Report
UNCTAD predicts the global cannabis market could reach $18.6 billion by 2027, if key issues are addressed.

According to a comprehensive industry report by the United Nations Conference on Trade and Development (UNCTAD), the global cannabis market could reach $18.6 billion by 2027 if countries around the world take action to clarify the legal status of marijuana and address other key issues.


According to a report from Hemp Today, citing data from Krungsri Research Intelligence, a research unit under the Bank of Ayudhya based in Bangkok, the market value of cannabis in the next five years could double the estimated $4.7 billion in 2020.


The report of the trade development conference covers:


Information: The authors of the report suggest that the cannabis industry needs increased transparency, including public data on all cannabis production outputs, specific country/region data, and pricing information. "At an international level, it is clear that the availability and accessibility of information needs to be improved. Efforts should be made to improve the current state of information on all aspects of this commodity.


The report suggests that other categories should be included, such as hemp seeds, hemp seed oil, hemp seed products, cannabis resin, and essential oils.


Sustainability: The report also indicates that environmental and social factors are "key to the success of any cannabis-related policy" and should therefore be considered within a broader legal and regulatory framework.


The report states that "to ensure the sustainable development of the global cannabis industry, cannabis cultivation can provide environmental benefits that can be taken into account in policies aimed at mitigating the impacts of climate change and restoring healthy ecosystems.


The report indicates that cannabis cultivation could potentially maximize land use and also increase income for farmers and rural communities, particularly in developing countries.


Industry Strategy: The Trade and Development Conference suggests that most regions of the world should consider a comprehensive cannabis cultivation strategy, stating that "given the relatively small size of the cannabis market and its inherent economic constraints, this approach is more viable." The document also notes that the comprehensive cultivation approach may lead to business opportunities in both primary and secondary markets, and that cannabis cultivation can further be monetized through the integration of voluntary carbon credit programs.


This 84-page report outlines the steps that the government can take to utilize the economic and social potential of marijuana, categorizes industrial hemp by output type, and demonstrates how the derivative products of this cannabis sub-industry are reflected in trade statistics.


According to the report, the cannabis value chain can promote growth in rural areas and contribute to manufacturing and food processing industries. However, in order to fully exploit this potential, countries may have to take specific actions. This represents the first international governmental organization document promoting the use of industrial hemp.


The report also addresses the legal issues surrounding marijuana. It notes that clarifying the legal status of marijuana as a non-narcotic substance is the first step the government should take in order to minimize legal and financial risks for producers.


The report suggests that all countries should permit the cultivation of non-intoxicating C. Sativa L. strains, despite the possibility of strict government control. Additionally, a method that promotes overall production and usage, rather than field THC thresholds, should be adopted for the benefit of the final product.


Alternatively, legislators could increase the THC threshold for "field" crops to the scientifically recognized non-toxic level. The report states, "This would increase the variety of strains available for use in the cannabis production chain, thus actually increasing the likelihood of cultivating strains that are best suited to specific environmental conditions and characteristics.


The report also suggests that additional production restrictions imposed by the regulatory framework must be identified and a regional cooperation strategy should be developed to establish a viable and sustainable value chain.


2FIRSTS will continue to follow and report on this topic, with future updates available on the "2FIRSTSAPP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa plans to publish its first vapor products directory on November 16, 2026, after which products not listed will be prohibited from sale or offer for sale in the state. The Department of Revenue expects to begin penalty enforcement on December 17, following an initial 21-business-day period focused on compliance education. Under House File 2677, retailers, distributors and wholesalers selling unlisted products face civil penalties of $300 per product per day, while manufacturers face $1,000 per product per day. Eligibility extends to FDA-authorized products and certain products meeting historical marketing and pending PMTA requirements. The directory program resumed after a federal appeals court vacated a preliminary injunction in July 2026.
Regulations
Nov.05
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11